|
Re: New exempt distribution
|
1
|
Resverlogix Corp.
|
May 06, 2021 04:24PM
|
|
Re: New exempt distribution
|
1
|
Resverlogix Corp.
|
May 06, 2021 04:34PM
|
|
Re: New exempt distribution
|
1
|
Resverlogix Corp.
|
May 06, 2021 07:03PM
|
|
Re: New exempt distribution
|
1
|
Resverlogix Corp.
|
May 06, 2021 07:21PM
|
|
Re: New Covid mutation on the radar -- 'Mu'
|
3
|
Resverlogix Corp.
|
Sep 01, 2021 12:40PM
|
|
Re: New Covid mutation on the radar -- 'Mu'
|
3
|
Resverlogix Corp.
|
Sep 01, 2021 01:39PM
|
|
Re: New Apabetalone Fabry Disease Publication
|
2
|
Resverlogix Corp.
|
Apr 29, 2022 02:45PM
|
|
Re: New Apabetalone Fabry Disease Publication
|
4
|
Resverlogix Corp.
|
Apr 29, 2022 03:17PM
|
|
Re: New Apabetalone Fabry Disease Publication
|
1
|
Resverlogix Corp.
|
Apr 29, 2022 03:37PM
|
|
Re: New Apabetalone Fabry Disease Publication
|
4
|
Resverlogix Corp.
|
Apr 28, 2022 06:31AM
|
|
Re: New Apabetalone Clinical Trial for Pulmonary Arterial Hypertension
|
|
Resverlogix Corp.
|
Sep 04, 2018 05:51AM
|
|
Re: New 52 high today? The pause that refreshes?
|
2
|
Resverlogix Corp.
|
May 03, 2019 10:23AM
|
|
Re: Negotiating with HL....
|
1
|
Resverlogix Corp.
|
Feb 04, 2019 12:03PM
|
|
Re: Naz listing?
|
4
|
Resverlogix Corp.
|
Apr 20, 2019 09:04AM
|
|
Re: Nature Article on the role of Endothelial Cells in COVID 19
|
2
|
Resverlogix Corp.
|
May 24, 2020 09:17AM
|
|
Re: Nature Article on the role of Endothelial Cells in COVID 19
|
2
|
Resverlogix Corp.
|
May 25, 2020 08:27AM
|
|
Re: National Kidney Foundation -Abstract: BOM
|
3
|
Resverlogix Corp.
|
Mar 30, 2020 03:17PM
|
|
Re: Nasdaq listing requirements - Another reason for this raise?
|
|
Resverlogix Corp.
|
May 30, 2019 03:47PM
|
|
Re: Nasdaq listing requirements - Another reason for this raise?
|
2
|
Resverlogix Corp.
|
May 30, 2019 09:30AM
|
|
Re: NASDAQ IPO questions
|
2
|
Resverlogix Corp.
|
Sep 09, 2018 06:07AM
|
